4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000068
Chief Accounting Officer returned 1,308 shares (to the company)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Azoy Alexander · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-18 | Returned to the company : show line 1 in the form 10b5-1 | −647 | $17.74 | $11,478 | 10,949 | D |
| 2023-12-19 | Returned to the company : show line 2 in the form 10b5-1 | −661 | $18.09 | $11,957 | 10,288 | D |
Loading xslF345X05/wk-form4_1703106610.xml…